Pfizer, Apotex To End Fight Over Generic Relpax
Pfizer Inc. notified a New York federal judge Tuesday that it was close to settling a patent infringement suit over rival Apotex Inc.'s plan to sell a generic version of the...To view the full article, register now.
Already a subscriber? Click here to view full article